Key result
Pulmonary embolism explains ~14% of acute COPD exacerbations lacking an obvious initial etiology.
Why the study?
The reported prevalence of pulmonary embolism in acute exacerbation of chronic obstructive pulmonary disease varies widely, and early detection is key to improving patient outcomes.
What is the prevalence and what are the predictors of pulmonary embolism in patients with acute exacerbation of COPD of unknown etiology?
Observational (n=100)
No
What is the prevalence and what are the predictors of pulmonary embolism in patients with acute exacerbation of COPD of unknown etiology?
Pulmonary embolism is a frequent unrecognized cause of acute exacerbation of COPD, occurring in 14% of cases without an obvious etiology, and should be suspected in patients presenting with chest pain, hemoptysis, or respiratory alkalosis.
Answers are grounded in this paper and cite their sources.
PE evaluation may be considered in select unexplained AECOPD; leaves open validation of predictors in prospective studies.
BACKGROUND: The prevalence of pulmonary embolism (PE) in patients of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) varies over a wide range. Early detection and treatment of PE in AECOPD is a key to improve patient outcome. The purpose of the study was to investigate the prevalence and predictors of PE in patients of AECOPD in a high burden region of North India. MATERIALS AND METHODS: This prospective study included patients of AECOPD with no obvious cause of exacerbation on initial evaluation. Apart from routine workup, the participants underwent assessment of D-dimer, compression ultrasound and venous Doppler ultrasound of the lower limbs and pelvic veins, and a multidetector computed tomography pulmonary angiography. RESULTS: A total of 100 patients of AECOPD with unknown etiology were included. PE as a possible cause of AE-COPD was observed in 14% of patients. Among the participants with PE, 63% (n = 9) had a concomitant presence of lower extremity deep venous thrombosis. Hemoptysis and chest pain were significantly higher in patients of AECOPD with PE ([35.7% vs. 7%, P = 0.002] and [92.9% vs. 38.4%, P = 0.001]). Likelihood of PE was significantly higher in patients who presented with tachycardia, tachypnea, respiratory alkalosis (PaCO2 <45 mmHg and pH >7.45), and hypotension. No difference was observed between the two groups in terms of in-hospital mortality, age, sex distribution, and risk factors for embolism except for the previous history of venous thromboembolism (35.7% vs. 12.8% P = 0.03). CONCLUSION: PE was probably responsible for AECOPD in 14% of patients with no obvious cause on initial assessment. Patients who present with chest pain, hemoptysis, tachypnea, tachycardia, and respiratory alkalosis should be particularly screened for PE.
No takes yet. Share an insight, caveat, or question.
Chaudhary et al. (2021) conducted an observational in Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) (n=100). Pulmonary embolism was identified as the probable cause of acute exacerbation in 14% of COPD patients with no obvious etiology on initial assessment.
Synapse has enriched 10 related papers. Consider them for comparative context: